USPTO serial 79006517
X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
Reviewed by CopyMark Law Group
Reg. 3283161Status 404
- Filing date
- Status date
- Registration date
- Aug 21, 2007
- Examiner
- BENJAMIN, SARA NICOLE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
LESLIE BERTAGNOLLI
LESLIE BERTAGNOLLI Baker & McKenzie LLP300 East Randolph Street, Suite 5000Chicago, IL 60601UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparation, namely an anti-hypertensive preparation | SECTION 71 - CANCELLED | — |
| 042 | Scientific research services for medical purposes, namely clinical studies in the field of hypertension | SECTION 71 - CANCELLED | — |
| 044 | Pharmacological consulting services; pharmaceutical and medical information services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOFARMA
- Other trademarks owned by BIOFARMA
- Other trademarks owned by BIOFARMA
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 29, 2015 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Apr 9, 2015 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Apr 9, 2015 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Nov 28, 2014 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 28, 2014 | C71T | CANCELLED SECTION 71 | — |
| May 21, 2012 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 3, 2011 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 19, 2008 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 10, 2007 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 10, 2007 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 28, 2007 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 21, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 5, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 16, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 5, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 5, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 2, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 2, 2007 | ALIE | ASSIGNED TO LIE | — |
| Feb 26, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 26, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2007 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 13, 2006 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 13, 2006 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 25, 2006 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 1, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 1, 2006 | PAPER RECEIVED | — | |
| May 25, 2006 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 11, 2006 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 11, 2006 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 3, 2006 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 2, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 29, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 16, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Oct 31, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 31, 2005 | PAPER RECEIVED | — | |
| Jun 9, 2005 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 25, 2005 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 20, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 10, 2004 | NWAP | NEW APPLICATION ENTERED | — |
| Dec 9, 2004 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |